This study plans to learn more about the feasibility and acceptability of integrating a survivorship nutrition program, called BfedBwell, into an existing clinical exercise oncology program, called BfitBwell. This study will also learn about the impact of the combined BfedBwell + BfitBwell program on changes in physical and mental health.
If you decide to be in the study, you will participate in the BfedBwell survivorship nutrition program for 6 months. The BfedBwell program has group education sessions, group support sessions, cooking demonstrations, and 1-on-1 counseling with a dietitian. You will also receive support for aerobic and resistance training through the BfitBwell exercise oncology program. Both programs are hybrid and have virtual and in-person sessions held at the Anschutz Health and Wellness Center.
Be age 18 to 75 years old; Have a diagnosis of any adult cancer within the past 10 years; Have finished all planned surgery, radiation, and chemotherapy treatments 3 or more months before the study starts; Have a body mass index (BMI) between 25 and 45 kg/m2; Live or work within 30 minutes of the Anschutz Medical Campus 1. Age 18-75 years 2. BMI 25-45 kg/m2 3. History of cancer within the past 10 years with a diagnosis of an adulthood cancer of any type 4. In maintenance or surveillance status, defined as completion of active cancer therapy (e.g., surgery, radiation, chemotherapy, immunotherapy) with curative intent at least 3 months and no more than 10 years prior to enrollment or active surveillance with no treatment; ongoing targeted or hormone therapies ≥3 months prior to intervention start date and/or ongoing maintenance therapy ≥1 year is permitted (exceptions to this timeframe for completion of other therapies can be made on a case-by-case basis by the PI if patients are tolerating therapy without adverse effects and will have completed active treatment or been in stable maintenance treatment prior to the intervention start date) 5. Have a primary care provider (or are willing to establish care with a primary care provider prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions and who will provide clearance to participate in a nutrition and exercise program 6. Ability and willingness to participate in a supervised exercise program; with ability assessed by the Physical Activity Readiness Questionnaire (PAR-Q+)74 and questions based upon National Comprehensive Cancer Network (NCCN) guidelines (note: any positive responses will trigger a required physician clearance form) 7. Speak English 8. Have access to a computer or smart phone and Internet to join Zoom meetings, complete questionnaires, and access/download the True Coach virtual exercise coaching sessions 9. Live or work within 30 miles of the AHWC (exceptions may be made at the discretion of the study PI on a case-by-case basis for highly motivated subjects) 10. Not be planning for major elective surgery, to travel for >2 consecutive weeks, or relocate/move during the intervention (~6 months) 11. No nicotine or tobacco use within previous 6 months 12. Agree to refrain from use of all nutritional supplements aside from those prescribed by a physician for the duration of the study 13. Capable and willing to give informed consent and understand exclusion criteria 14. Willing to attend weekly small group education sessions and some, none, or all of the following: monthly behavioral skills development sessions, weekly group support sessions and/or monthly 1:1 counseling held by a registered dietitian (RD) 15. Willing to attend up to two BfitBwell exercise sessions (one in person, one virtual) per week for first 12 weeks then once monthly in person and once weekly virtual sessions for second 12 weeks 16. Not meeting dietary guidelines [i.e., Healthy Eating Index (HEI) score <80 as assessed via NCI DHQ III food frequency questionnaire] or physical activity guidelines [i.e., <150 minutes moderate/vigorous activity per week via self-report on Godin-Shephard Leisure-Time Physical Activity Questionnaire] (exceptions may be made at the discretion of the study PI on a case-by-case basis for highly motivated subjects)
Protocol Number: 26-0077
More information available at ClinicalTrials.gov: NCT07446595
Principal Investigator